11 – 20 of 102
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Analytical validation of OncoMasTR, a multigene test for predicting risk of distant recurrence in hormone receptor-positive early stage breast cancer
2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.65-65(
- Contribution to journal › Published meeting abstract
-
Mark
A phase III study of INCB054828 as adjuvant therapy in patients (pts) with high-risk urothelial carcinoma (UC) harboring fibroblast growth factor receptor 3 (FGFR3) genomic alterations
2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.328-328(
- Contribution to journal › Article
-
Mark
Intermediate prognosis in metastatic germ cell tumors (IPGCT) : Outcome and prognostic stratification
2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29. p.325-325(
- Contribution to journal › Article
- 2016
-
Mark
Cancer mortality in cohorts of workers in the European rubber manufacturing industry first employed since 1975.
(
- Contribution to journal › Article
-
Mark
Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic
(
- Contribution to journal › Article
-
Mark
A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial
(
- Contribution to journal › Article
- 2015
-
Mark
Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival
(
- Contribution to journal › Article
-
Mark
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.
(
- Contribution to journal › Article
-
Mark
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
(
- Contribution to journal › Article
- 2014
-
Mark
Cancer risk in amyloidosis patients in Sweden with novel findings on non-Hodgkin lymphoma and skin cancer
(
- Contribution to journal › Article